Lobbying

Kazmira's latest lobbying report covers Q3 2023, at $20K. Its first report covers Q2 2023; the issues it reports most are Medical/Disease Research/Clinical Labs.

Kazmira

Latest quarter
No record
Q2 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q2 2026 against the quarter before
First report
Q2 2023
The first quarter a report named it

Lobbying by quarter

Kazmira lobbying by quarter
Kazmira lobbying by quarter
QuarterAmountReports
Q2 2023$20K1
Q3 2023$20K1
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00

Policy issues the reports name

  • Medical research and clinical labs2 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES2 reports
  • SENATE2 reports

Firms it paid

Firm
Crossroads Strategies$40K2 quarters

Former officials lobbying for it

Former position
BRITTANY JOHNSON HERNANDEZSenior Legislative Assistant, Legislative Assistant, Legislative Correspondent, Staff Assistant: Rep. Steve CohenQ3 2023

Lobbying reports

Filed by
24/01/12for Q3 2023Crossroads Strategies$20K
23/10/20for Q3 2023Crossroads Strategies$20K
23/07/19for Q2 2023Crossroads Strategies$20K
23/05/24for Q2 2023Crossroads StrategiesUnder $5,000